Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma. Shan E, Cao YN, Zhang Y, Chen W, et al. BMC Cancer 2023;23:846.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shan E, Cao YN, Zhang Y, Chen W, et al. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma. BMC Cancer 2023;23:846.
PMID: 37697240